Anand Devasthanam

Anand Devasthanam is a seasoned professional in medical and scientific communication with extensive experience across various roles in the pharmaceutical and healthcare sectors. Currently serving as a Senior Scientific Advisor at IQVIA since April 2025, Anand manages complex projects while ensuring compliance with regulatory guidelines and collaborates with cross-functional teams. Prior experience includes serving as Medical Director at Havas Life Rare, where responsibility for the integrity of medical programs was paramount, and as Associate Director of Medical Strategy at 21GRAMS, where strategic insights informed educational materials. Additionally, Anand has held roles as Associate Medical Director at Syneos Health, overseeing content strategy, and as a Medical Writer at PAREXEL, focusing on clinical documents for FDA submissions.